Groww Logo
Home>US Stocks>Gilead Sciences Inc.

Gilead Sciences Inc.

Healthcare
$63.18
+ $0.94 (1.51%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $62.42$62.245,607,7438,407,017

      Fundamentals

      Market Cap$79.24B
      P/B Ratio4
      P/E Ratio17.6
      Enterprise Value$101.15B
      Div. Yield4.69%
      Book Value15.88
      EPS(TTM)0.02
      ROENA
      Understand Fundamentals

      About the Company

      Founded in 1987, Gilead Sciences Inc. is a biopharmaceutical company that develops, researches and commercialises drugs. It is headquartered in Foster City, California, and as of 2020, employs 11,800 individuals across its research centres and other
      Founded in 1987, Gilead Sciences Inc. is a biopharmaceutical company that develops, researches and commercialises drugs. It is headquartered in Foster City, California, and as of 2020, employs 11,800 individuals across its research centres and other operations. The company is best known for Harvoni and Sovaldi, its Hepatitis C cures. Some of the locations where it conducts operations include Miami, Santa Monica, La Verne, Seattle, Emeryville etc. As of 2020, it has or is developing medicines for issues like liver diseases, cardiovascular, inflammation/respiratory, haematology/oncology and COVID-19 along with few others. Some of its medicines include Atripla, Genvoya, Complera, Veklury, Harvoni, Vosevi, Trodelvy, Macugen, Letairis, Yescarta, etc. The company has 3 Breakthrough Therapy Designations; 12 NDA/BLA/MAA, P3 and Registrational P2 trials; 42 Clinical Stage Programs; and 17 NMEs via In-Licensing, Options, and Product Acquisitions. It is testing potential treatment compounds of HBV, emerging virus, cell therapy, inflammatory diseases, non-cell therapy, HIV and fibrotic diseases. It entered the Fortune 500 family in 2009 and holds the 140th place as of 2020. Gilead is a component in the S&P 500, S&P 100, NASDAQ 100 and NASDAQ Biotechnology indices as of the same year. It trades in the NASDAQ stock exchange under the ticker symbol GILD. In 2020, Forbes has recognised it in its Global 2000, Best Employers For Diversity and World’s Best Employers lists. Gilead Sciences was founded in 1987 as Oligogen by a medical doctor named Michael L. Riordan. Back then its primary focus was on antiviral medicines and started its early research on small strands of DNA. Its name soon changed to Gilead Sciences after the ancient Balm of Gilead that was known for its healing properties. Its first substantial acquisition was in 1999 with NeXstar Pharmaceuticals. Between 2003 and 2020, it acquired companies like Triangle Pharmaceutical in 2003, Myogen, Inc., Raylo Chemicals and Corus Pharma, Inc. in 2006, CV Therapeutics, Inc. in 2009, CGI Pharmaceuticals in 2010, Calistoga Pharmaceuticals in 2011, Phenex Pharmaceuticals in 2015, Nimbus Apollo, Inc. in 2016, Immunomedics in 2020, etc.
      ...Read more
      OrganisationGilead Sciences Inc.
      IndustryDrug Manufacturers—General
      HeadQuartersFoster City, CA

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on Gilead Sciences Inc.

      Can I Buy Gilead Sciences Inc. Shares in India?

      Yes, Gilead Sciences Inc. shares can be bought in India by opening an international trading account with Groww.

      How to Buy Gilead Sciences Inc. Shares in India?

      One can easily invest in Gilead Sciences Inc. shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Gilead Sciences Inc. shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Gilead Sciences Inc..

      What is the Share Price of Gilead Sciences Inc.?

      The share price of Gilead Sciences Inc. is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Gilead Sciences Inc. share price is $63.18 as of 17 May ‘22

      What is the Market Cap of Gilead Sciences Inc.?

      The Gilead Sciences Inc. market cap is $79.24B as of 17 May ‘22

      What is the PE and PB ratio of Gilead Sciences Inc.?

      The PE and PB ratio of Gilead Sciences Inc. is 17.6 and 4 as of 17 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.3.8
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW